Using multiple databases, we comprehensively analyzed the correlation between ABCD3 mRNA and protein expression levels and clinical glioma patient characteristics, immune infiltration, gene enrichment analysis, etc. We conclude that ABCD3 is highly expressed in different degrees of gliomas and is associated with poor prognosis and many clinical characteristics. The gene discussed is ABCD3; the disease is central nervous system cancer.